Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Anchor lead: A genetic assay can help many with early breast cancer avoid chemotherapy, Elizabeth Tracey reports A widely available 21-gene assay can help women with so-called intermediate risk breast cancer avoid chemotherapy and simply stick to endocrine therapy, a …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Anchor lead: Using chemotherapy inside the bladder may reduce recurrence, Elizabeth Tracey reports People with early bladder cancer who had the chemotherapy drug gemcitabine placed inside the bladder following surgery to remove the tumor had fewer recurrences, a recent study …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Anchor lead: Targeted therapies have a role in the treatment of melanoma, Elizabeth Tracey reports Therapies targeting a pathway known as ‘programmed cell death’ or PDL-1 have been shown to be beneficial in people with advanced melanoma, the most deadly …
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
Anchor lead: MRI helps when it comes to prostate biopsy, Elizabeth Tracey reports Using magnetic resonance imaging or MRI, in conjunction with ultrasound guidance, improved detection of cancer in prostate biopsies, a recent study in the New England Journal of …
Podcast: Download (Duration: 1:07 — 1.5MB)
Subscribe: RSS
Anchor lead: New guidelines for prostate cancer screening have been released, Elizabeth Tracey reports If you’re a man, should you undergo prostate specific antigen or PSA screening for prostate cancer? The United States Preventive Services Task Force, known by the …
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Anchor lead: Can eating a Mediterranean-type diet improve cancer survival? Elizabeth Tracey reports People with colon cancer who had been treated for their cancer and who consumed a healthy diet, were physically active and practiced other healthful behaviors lived longer …
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Anchor lead: A new estimate shows just how few people with cancer are entering clinical trials, Elizabeth Tracey reports Science magazine has just published a comprehensive view of the cancer landscape, with one observation that if immunotherapies are going to …
